THE COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF CARDIOVASCULAR (CV) EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS) IN TURKEY

Date
2014
Author
Afsar, N.
Aykut Aka, S.
Degertekin, M.
Ergene, O.
Ongen, Z.
Ozdemir, M.
Sumer, F.
Yilmaz, Z. S.
Ozel, M. O.
Parali, E.
Deger, C.
Ozdemir, O.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/53218
https://doi.org/10.1016/j.jval.2014.03.672
Collections